Learn about Dr. Mario Sznol and his work in immune therapies for the last 35 years for melanoma and kidney cancer, and how the clinic and the lab work together to offer patients the best investigational therapies available.
Featured Stories
A Patient Partnership in Care and Research
For the past 16 years, Dick Metz has experienced the ups and downs of a cancer diagnosis.
Bill Brown: Melanoma Survivor
Dr. Harriet Kluger helped Bill participate in a clinical trial with ipilimumab in combination with an anti-PD1 drug, Nivolumab to treat his stage III melanoma.
Dina: Melanoma Survivor
Due to the severity of Dina's diagnosis, Dr. Mario Sznol suggested she join a clinical trial that offered a combined immunotherapy, which at the time was a very new therapy.
Richard: Melanoma Survivor
Mr. Metz’s journey illustrates the incredible strides that have been made in treating melanoma, a cancer that just ten years ago had a much more frightening prognosis.
Sun Damage Occurs even after Sunset
Researchers at Yale discovered that sun damage continues even when we’re out of the sun and that melanin, the pigment that gives skin its color, may be both protective and harmful.
A One-Two Punch Against Melanoma
In a phase I trial, a new combination of drugs proved highly effective against an especially dangerous cancer: melanoma.
Smilow Shares in partnership with Melanoma Research Foundation | October 12, 2021Presentations by: Jonathan Leventhal, MD, Assistant Professor of Dermatology
Thuy Tran, MD, PhD, Instructor of Medicine (Medical Oncology)
Kelly Olino, MD, Assistant Professor of Surgery (Surgical Oncology)
James Clune, MD, Assistant Professor of Surgery (Plastic)
Jeffrey Ishizuka, MD, DPhil, Assistant Professor of Medicine (Medical Oncology)
July 13, 2021 | Presentations by Drs. Richard Connors, Bruce McGibbon, and Sajid Khan
Melanoma Awareness Month 2020
Reconstructive Surgery for Melanoma and Skin Cancers
Surgical Options for Skin Cancer and Melanoma